This protocol addresses pleurisy occurring specifically in the setting of post-cardiac injury syndrome — an inflammatory response that can follow cardiac surgery, myocardial infarction, or other cardiac injury events, and that may involve pleural inflammation as part of its presentation.
First-line management is built around a specific class of anti-inflammatory agents. The complete regimen — covering agent selection, sequencing, and the criteria for escalation — is detailed in the full structured protocol.
NSAIDs are first-line therapy for patients with post–cardiac injury syndrome; corticosteroids are reserved for those who are intolerant of or experience no response to NSAIDs.
View source ↗